Free Trial

The Pennant Group (PNTG) Competitors

The Pennant Group logo
$24.63 -0.57 (-2.26%)
Closing price 04:00 PM Eastern
Extended Trading
$24.60 -0.03 (-0.12%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PNTG vs. CON, SGRY, PRVA, HTFL, VCYT, CELC, LFST, ADUS, PGNY, and ARDT

Should you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), Heartflow (HTFL), Veracyte (VCYT), Celcuity (CELC), LifeStance Health Group (LFST), Addus HomeCare (ADUS), Progyny (PGNY), and Ardent Health (ARDT). These companies are all part of the "healthcare" industry.

The Pennant Group vs. Its Competitors

The Pennant Group (NASDAQ:PNTG) and Concentra Group Holdings Parent (NYSE:CON) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.

Concentra Group Holdings Parent has a net margin of 7.44% compared to The Pennant Group's net margin of 3.36%. Concentra Group Holdings Parent's return on equity of 50.84% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group3.36% 9.85% 4.04%
Concentra Group Holdings Parent 7.44%50.84%5.89%

The Pennant Group has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500. Comparatively, Concentra Group Holdings Parent has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

85.9% of The Pennant Group shares are owned by institutional investors. 5.4% of The Pennant Group shares are owned by company insiders. Comparatively, 6.6% of Concentra Group Holdings Parent shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Concentra Group Holdings Parent had 1 more articles in the media than The Pennant Group. MarketBeat recorded 4 mentions for Concentra Group Holdings Parent and 3 mentions for The Pennant Group. Concentra Group Holdings Parent's average media sentiment score of 1.67 beat The Pennant Group's score of 0.86 indicating that Concentra Group Holdings Parent is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Concentra Group Holdings Parent
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Concentra Group Holdings Parent has higher revenue and earnings than The Pennant Group. Concentra Group Holdings Parent is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$695.24M1.22$22.56M$0.7831.58
Concentra Group Holdings Parent$1.90B1.44$166.54M$1.1917.98

The Pennant Group currently has a consensus target price of $34.40, suggesting a potential upside of 39.67%. Concentra Group Holdings Parent has a consensus target price of $27.50, suggesting a potential upside of 28.50%. Given The Pennant Group's higher possible upside, equities analysts clearly believe The Pennant Group is more favorable than Concentra Group Holdings Parent.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
Concentra Group Holdings Parent
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Concentra Group Holdings Parent beats The Pennant Group on 12 of the 16 factors compared between the two stocks.

Get The Pennant Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PNTG vs. The Competition

MetricThe Pennant GroupMED IndustryMedical SectorNASDAQ Exchange
Market Cap$870.96M$5.39B$5.69B$10.27B
Dividend YieldN/A1.28%5.72%4.60%
P/E Ratio30.7328.6075.8626.51
Price / Sales1.22162.97489.92165.26
Price / Cash27.3326.8725.8129.89
Price / Book2.714.4612.846.32
Net Income$22.56M$189.47M$3.28B$270.51M
7 Day Performance-0.81%-2.58%0.22%2.15%
1 Month Performance-2.49%1.63%4.61%6.35%
1 Year Performance-29.47%13.58%68.33%25.48%

The Pennant Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PNTG
The Pennant Group
4.2554 of 5 stars
$24.63
-2.3%
$34.40
+39.7%
-27.0%$870.96M$695.24M30.737,000
CON
Concentra Group Holdings Parent
3.0905 of 5 stars
$21.26
-4.0%
$27.50
+29.3%
-8.0%$2.84B$1.90B17.8711,250Positive News
SGRY
Surgery Partners
3.2012 of 5 stars
$21.60
-1.2%
$33.00
+52.8%
-30.3%$2.80B$3.11B-15.1015,000Positive News
PRVA
Privia Health Group
4.4116 of 5 stars
$22.34
-2.0%
$28.58
+27.9%
+17.9%$2.80B$1.74B203.111,140Positive News
HTFL
Heartflow
N/A$32.89
-1.5%
$35.80
+8.8%
N/A$2.71BN/A0.00699Positive News
Quiet Period Expiration
VCYT
Veracyte
3.7619 of 5 stars
$31.87
+3.2%
$40.90
+28.3%
-3.2%$2.43B$479.13M96.58790Positive News
CELC
Celcuity
1.5024 of 5 stars
$55.07
+0.3%
$56.50
+2.6%
+267.6%$2.33BN/A-15.9640
LFST
LifeStance Health Group
3.4904 of 5 stars
$5.18
-1.0%
$8.50
+64.1%
-25.4%$2.03B$1.25B-103.6010,218Positive News
ADUS
Addus HomeCare
4.986 of 5 stars
$109.27
-0.9%
$138.89
+27.1%
-16.0%$2.03B$1.15B24.1249,703Positive News
PGNY
Progyny
3.9109 of 5 stars
$22.13
-1.7%
$25.30
+14.3%
-8.4%$1.94B$1.24B37.51310Positive News
ARDT
Ardent Health
3.471 of 5 stars
$12.65
-3.3%
$19.33
+52.8%
-30.3%$1.87B$5.97B6.9924,900Positive News

Related Companies and Tools


This page (NASDAQ:PNTG) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners